Recurrent Head and Neck Carcinoma

Known as: Recurrent Head and Neck Cancer 
The reemergence of carcinoma in the head and neck region after a period of remission.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
PURPOSE We report early preliminary experience with CyberKnife radiosurgery (RS) as salvage treatment for locally recurrent head… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
The aim of this clinical trial was to investigate the feasibility of intra-arterial infusion of in vitro-expanded Valpha24… (More)
Is this relevant?
2006
2006
The aim of this study was to assess the feasibility and toxicity of stereotactic radiosurgery (CK-SRS) using the CyberKnife… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE Therapy of recurrent/metastatic squamous cell carcinoma of the head and neck results in median progression-free survival… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
PURPOSE Surgeons treating patients with head and neck squamous cell carcinoma (HNSCC) rely heavily on histology to decide whether… (More)
  • table 1
  • table 2
  • figure 1
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Interstitial photodynamic therapy (IPDT) is a technique for applying photodynamic therapy (PDT) to internal tumours using light… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2000
Highly Cited
2000
ONYX-015 is an adenovirus with the E1B 55-kDa gene deleted, engineered to selectively replicate in and lyse p53-deficient cancer… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2000
Highly Cited
2000
An E1B 55 kDa gene-deleted adenovirus, Onyx-015, which reportedly selectively replicates in and lyses p53-deficient cells, was… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Highly Cited
2000
Highly Cited
2000
PURPOSE Earlier detection of head and neck cancer recurrence may improve survival. We evaluated the ability of [(18)F… (More)
Is this relevant?
Highly Cited
1992
Highly Cited
1992
PURPOSE To determine whether combination chemotherapy is superior to single agents for recurrent/metastatic head and neck cancer… (More)
Is this relevant?